{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:48Z","timestamp":1791566448486,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaut.2022.102941","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T11:48:51Z","timestamp":1667130531000},"page":"102941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-2110","authenticated-orcid":false,"given":"Pierre","family":"Bay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Pineton","family":"de Chambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Mahevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"De Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique Isra\u00ebl","family":"Biet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hervier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Tazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Deligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Meurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Priou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"De Saint Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gallay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Brillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Khafagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilario","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurdag\u00fcl","family":"Uzunhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2022.102941_bib1","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2022.102941_bib2","series-title":"Clinical Features and Outcome of Patients with Acute Respiratory Failure Revealing Anti-synthetase or Anti-MDA-5 Dermato-Pulmonary Syndrome: a French Multicenter Retrospective Study","author":"Vuillard","year":"2018"},{"key":"10.1016\/j.jaut.2022.102941_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac094","article-title":"Predictors of rapidly progressive- interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis","author":"So","year":"2022","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaut.2022.102941_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","article-title":"Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease","volume":"50","author":"Romero-Bueno","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jaut.2022.102941_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.chest.2016.04.007","article-title":"Management of myositis-related interstitial lung disease","volume":"150","author":"Morisset","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2022.102941_bib6","author":"Tsuji","year":"2019"},{"issue":"3","key":"10.1016\/j.jaut.2022.102941_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMc1900045","article-title":"Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2022.102941_bib8","first-page":"keab928","article-title":"Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis","author":"Wang","year":"2021","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.jaut.2022.102941_bib9","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1093\/rheumatology\/keaa123","article-title":"Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment","volume":"59","author":"Shirakashi","year":"2020","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaut.2022.102941_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/kez357","article-title":"Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy","volume":"59","author":"Abe","year":"2020","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2022.102941_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jca.21824","article-title":"Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia","volume":"35","author":"Yamagata","year":"2020","journal-title":"J. Clin. Apher."},{"issue":"2","key":"10.1016\/j.jaut.2022.102941_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.55563\/clinexprheumatol\/brvl1v","article-title":"Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management","volume":"40","author":"Hallowell","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2022.102941_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a fleischner society white paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jaut.2022.102941_bib14","series-title":"Forced Vital Capacity Predicts the Survival of Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis: a Multi-Centre Cohort Study","author":"Wu","year":"2021"},{"issue":"Issue 10","key":"10.1016\/j.jaut.2022.102941_bib15","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/rheumatology\/keac030","article-title":"Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients","volume":"October 2022","author":"Hensgens","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102941_bib16","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/di1083","article-title":"Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies","author":"Cavagna","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2022.102941_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jaut.2022.102941_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/keab586","article-title":"Clinical role of bronchoalveolar lavage in dermatomyositis-associated interstitial lung disease","volume":"61","author":"He","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2022.102941_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.24372","article-title":"Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis","volume":"61","author":"Le Goff","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jaut.2022.102941_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10067-015-3001-3","article-title":"Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum","volume":"35","author":"Ma","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2022.102941_bib21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s10067-019-04918-2","article-title":"Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis","volume":"39","author":"Zhou","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2022.102941_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-004-2187-7","article-title":"Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients","volume":"30","author":"Anzueto","year":"2004","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.jaut.2022.102941_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1684\/ejd.2019.3634","article-title":"Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease","volume":"29","author":"Motegi","year":"2019","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2022.102941_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fmed.2020.00363","article-title":"Predictors and mortality of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathy: a series of 474 patients","volume":"7","author":"Li","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2022.102941_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02968-2021","article-title":"Extracorporeal life support allows lung transplant in anti-mda5+ rapidly progressive-interstitial lung disease","author":"Bay","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.jaut.2022.102941_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.jaut.2022.102941_bib27","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jaut.2022.102941_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"Sato","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2022.102941_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"7089","key":"10.1016\/j.jaut.2022.102941_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaut.2022.102941_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coi.2008.01.002","article-title":"MDA5\/RIG-I and virus recognition","volume":"20","author":"Takeuchi","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2022.102941_bib32","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/rheumatology\/kev192","article-title":"The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis","volume":"54","author":"Kurita","year":"2015","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2022.102941_bib33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/rheumatology\/kez394","article-title":"Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis\/dermatomyositis: a single-arm clinical trial","volume":"59","author":"Takada","year":"2020","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.jaut.2022.102941_bib34","first-page":"1719","article-title":"Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis","volume":"32","author":"Kameda","year":"2005","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2022.102941_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"11","key":"10.1016\/j.jaut.2022.102941_bib36","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2022.102941_bib37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2012.11145.x","article-title":"Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease","volume":"167","author":"Sun","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.jaut.2022.102941_bib38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.it.2019.10.009","article-title":"Stimulation of innate immunity by host and viral RNAs","volume":"40","author":"Streicher","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2022.102941_bib39","first-page":"keab371","article-title":"Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease","author":"Gono","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2022.102941_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13075-021-02606-8","article-title":"High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center","volume":"23","author":"Huang","year":"2021","journal-title":"Arthritis Res. Ther."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:33:05Z","timestamp":1760257985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"alternative-id":["S0896841122001494"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102941","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102941"}}